KMT2A and acute myeloid leukemia: MLL rearrangements (MLL-r) resemble those found in secondary acute myeloid leukemia (AML) resulting from exposure to topoisomerase II inhibitors, what makes it a model for leukemogenesis in EAL with MLL-r.